🇺🇸 FDA
Pipeline program

BIOTIN, Medebiotin Fuerte solución inyectable, Medebiotín Fuerte Comprimidos

IMPRIMIDO

Phase 3 small_molecule active

Quick answer

BIOTIN, Medebiotin Fuerte solución inyectable, Medebiotín Fuerte Comprimidos for Metilcrotonilglicinuria, biotinidasa deficit is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Metilcrotonilglicinuria, biotinidasa deficit
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials